SEATTLE, March 6, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today
announced that it will conduct a conference call on Thursday, March 13,
2014 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its full
year and fourth quarter 2013 financial results and provide a review of
its pipeline of products in development.
To participate in the call by telephone, please dial (877) 280-7291
(United States) or (707) 287-9361 (International). In addition, the
call will be webcast live and can be accessed on the "Events" page of
the "News & Events" section of Oncothyreon's website at www.oncothyreon.com. An archive of the webcast will be available after completion of the
discussion and will be posted on the Oncothyreon website.
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.